PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
60.29
ESG score near Healthcare median of 62.00. David Dodd would investigate if industry-standard ESG practices adequately address sector-specific risks.
50.00
Environmental score 80-90% of Healthcare median of 59.24. Martin Whitman would look for hidden carbon liabilities and stranded asset risks.
62.54
Social score near Healthcare median of 63.99. David Dodd would investigate if industry-standard social practices adequately address stakeholder risks.
68.32
Governance score 1.1-1.2x Healthcare median of 63.36. Philip Fisher would examine if superior governance practices support long-term value creation.